The IFN-γ secretion of PBMCs in patients with moderate COVID-19 was higher than that in patients with severe COVID-19 and HDs (moderate vs. HD, p < 0.0001; moderate vs. severe, p < 0.0001) (Figure 1B,C). This evidence concerns the gene IFNG and COVID-19.